Role of circulatory leukocyte based indices in short-term mortality of patients with heart failure with reduced ejection fraction

Authors

  • Mohammadreza Taban Sadeghi
  • Ilqhar Esgandarian
  • Masoud Nouri-Vaskeh
  • Ali Golmohammadi
  • Negin Rahvar
  • Abedin Teimourizad

DOI:

https://doi.org/10.15386/mpr-1644

Keywords:

heart failure, neutrophils, monocytes, lymphocytes, neutrophil to lymphocyte ratio, survival

Abstract

Background. Pro-inflammatory signaling is mediated by a variety of inflammatory mediators which can cause myocardial apoptosis, hypertrophia, and fibrosis, and also ultimately lead to adverse cardiac remodeling. This study aimed to assess the role of circulating leukocyte-based indices in predicting the short-term mortality in patients with heart failure with reduced ejection fraction (HFrEF).

Methods. In a retrospective study, patients with HFrEF admitted to a tertiary referral center between January 2016 and January 2017 were recruited to this study. The association between neutrophil to lymphocyte ratio (NLR), derived neutrophil to lymphocyte ratio (dLNR = neutrophils/(leukocytes-neutrophils)), monocyte/granulocyte to lymphocyte ratio (MGLR = (white cell count-lymphocyte count) to lymphocyte count), platelet to lymphocyte ratio (PLR) and six-months mortality of patients were assessed.

Results. A total of 197 patients with HFrEF were enrolled in the study. NLR (P<0.001), dNLR (P<0.001), MGLR (P<0.001), PLR (P=0.006) and LVEF (P=0.042) showed significant difference between survived and died patients. In the Cox multivariate analysis we did not find NLR, dLNR, MGLR or PLR as an independent predictor of short-term mortality in HFrEF patients.

Conclusions. Although High NLR, PLR, MGLR and dNLR was associated with short-term mortality, it failed to independently predict the prognosis of HFrEF patients.

Downloads

Published

2020-09-08

How to Cite

1.
Taban Sadeghi M, Esgandarian I, Nouri-Vaskeh M, Golmohammadi A, Rahvar N, Teimourizad A. Role of circulatory leukocyte based indices in short-term mortality of patients with heart failure with reduced ejection fraction. Med Pharm Rep [Internet]. 2020 Sep. 8 [cited 2025 Oct. 5];93(4):351-6. Available from: https://medpharmareports.com/index.php/mpr/article/view/1644

Issue

Section

Original Research